Harriet Lane Handbook
Dolasetron
Anzemet
Antiemetic agent, 5-HT3 antagonist
| B | ? | Yes | Yes | No |
| Key |
- Tabs: 50 mg
- Oral suspension: 10 mg/mL
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Dolasetron." Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/2/Dolasetron.
Dolasetron. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/2/Dolasetron. Accessed April 30, 2026.
Dolasetron. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/2/Dolasetron
Dolasetron [Internet]. In: Hughes HKH, Kahl LKL, editors. Harriet Lane Handbook. Elsevier; 2024. [cited 2026 April 30]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/2/Dolasetron.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dolasetron
ID - 309388
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309388/2/Dolasetron
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -
